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Lysine-241 Has a Role in Coupling 2OG Turnover with
Substrate Oxidation During KDM4-Catalysed Histone
Demethylation
Rebecca L. Hancock,[a] Martine I. Abboud+,[a] Tristan J. Smart+,[a] Emily Flashman,[a]
Akane Kawamura,[a] Christopher J. Schofield,*[a] and Richard J. Hopkinson*[a, b]
The JmjC histone lysyl demethylases (KDMs) play important
roles in modulating histone methylation states and have the
potential to be regulated by oxygen availability. Lys241 of the
KDM4 subfamily is proposed to be important in oxygen bind-
ing by KDM4A. We report evidence that, although Lys241 is
unlikely to be directly involved in oxygen binding, it has an im-
portant role in coupling 2-oxoglutarate cosubstrate oxidation
with lysine demethylase activity. The results suggest that com-
pounds promoting the uncoupling of substrate oxidation are
of interest as JmjC-KDM inhibitors.
Histone lysyl demethylases (KDMs) regulate gene transcription
by catalysing the demethylation of methylated lysine residues
on the N-terminal tails of histones.[1] Although the first KDMs
to be identified, KDM1A/B, are amine oxidases,[2] the majority
of KDMs, that is, the human KDM2–7 subfamilies, are Jumonji-
C (JmjC) domain-containing 2-oxoglutarate (2OG) and iron(II)-
dependent dioxygenases (JmjC-KDMs).[3] JmjC-KDMs couple
the hydroxylation of methyllysine residues to the oxidative
decarboxylation of 2OG, producing succinate and CO2 ; the re-
sultant hydroxylated lysyl N-methyl group is an unstable hemi-
aminal that fragments to give the demethylated lysine and
formaldehyde (Scheme 1).[4]
Despite their structural and mechanistic similarities, the
KDM2–7 enzymes have diverse sequences and methylation
state specificities.[5] KDM4A–E are perhaps the best studied of
the JmjC-KDMs, and accept mono-, di- and trimethylated
lysines as substrates; KDM4 catalysis has been observed at
H3K9, H3K36 (KDM4A–C) and H1.4K26 (KDM4A–D).[6] KDM4A/E
have also been reported to catalyse the demethylation of N-
methylated arginines in the context of histone fragment pep-
tides.[7]
Abnormal expression patterns of JmjC-KDMs have been
linked to multiple diseases and disorders including in autism,[8]
cardiac hypertrophy,[9] mid-line defects[10] and several can-
cers.[11] Consequently, modulating KDM activity is of medicinal
interest. However, therapeutic targeting of KDMs is currently
compromised by an incomplete understanding of their bio-
chemical and physiological roles. For example, it is possible
that KDM catalysis is regulated by the availability of O2 within
some cells, although evidence for the physiological relevance
of such regulation is incomplete.[12]
X-ray crystal structures of KDM4 enzymes in complex with
substrate peptides have been reported and provided insights
into mechanism and a basis for inhibition studies.[1] An early
crystallographic and mutagenesis study on KDM4A by Chen
et al. identified a catalytically essential active-site lysine residue
(K241) that was proposed to regulate O2 binding
(Scheme 1);[13] hence K241 is potentially involved in regulating
the O2 sensitivity of KDM4s. K241, which is conserved within
the KDM4 subfamily but absent in other KDMs, is therefore an
attractive target residue for KDM4-selective inhibitors.
Here, we report biochemical studies assessing the role of
K241 in KDM4A catalysis. The results reveal that the K241A
KDM4A variant is capable of catalysing substrate-uncoupled
oxidative decarboxylation of 2OG at comparable efficiency to
wild-type KDM4A, thus implying a similarly efficient reaction
with O2 (at least for uncoupled turnover). Demethylation of a
trimethylated H3K9 peptide by K241A KDM4A was also ob-
served, although the catalysis was markedly less efficient than
for wild-type KDM4A, and demethylation activity was not in-
creased upon increasing the O2 concentration. Binding analy-
ses by fluorescence polarisation indicate similar binding effi-
ciencies of the histone substrate to both the WT enzyme and
the K241A variant. Overall, the results imply that K241 is im-
portant in KDM4A catalysis; although it does have a role in
coupling 2OG oxidation and demethylation, it is unlikely to be
involved in regulating O2 binding.
Initially, we produced two recombinant variants of KDM4A
(residues 1–359) in Escherichia coli BL21(DE3) cells ; a truncated
wild-type sequence (KDM4A WT), or a variant with an alanine
in place of Lys241 (K241A KDM4A). Studies were then carried
out to evaluate the ability of the two KDM4A proteins to cata-
lyse the demethylation of a histone peptide substrate. The two
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proteins (1 mm) were individually incubated with 2OG (100 mm,
a concentration well above its WT KM value of 26:7 mm),[12b]
ascorbate (100 mm), ferrous iron (10 mm) and a 15-residue
H3K9me3 peptide (100 mm, sequence: ARTKQTARKme3STGG-
KA) in HEPES buffer (50 mm, pH 7.5) at 37 8C; the extent of the
reaction was determined by using MALDI-TOF mass spectrom-
etry after 40 min. Substantial demethylation of the H3K9me3
peptide was observed in the sample with WT KDM4A, resulting
in formation of both di- and monomethylated products
(H3K9me2 and H3K9me1 respectively, Figure 1A). The K241A
variant, however, manifested only minimal KDM activity; no
H3K9me1 or unmethylated peptide (H3K9me0) was evident, al-
though low levels of H3K9me2 were observed (Figure 1A). De-
methylation was not increased by increasing the concentration
of 2OG to 2 mm (Figures S1 and S2 in the Supporting Informa-
tion). These findings suggest that K241 is required for efficient
KDM activity, thus supporting previous work that also em-
ployed MS.[13] Minimal K241A KDM4A-catalysed demethylation
activity was observed with other histone fragment peptides re-
ported to be KDM4A substrates (Figure 1B).
Given the role of K241 in O2 binding/recruitment proposed
by Chen et al. ,[13] we postulated that the lack of KDM activity
might be due to reduced binding of O2.
1H NMR analyses were
therefore carried out to assess the ability of the WT and K241A
KDM4A to catalyse substrate-uncoupled turnover of 2OG to
succinate, a process that requires O2 binding. Samples contain-
ing either WT or K241A (20.5 mm), an excess of 2OG (2 mm), as-
corbate (1 mm), and ferrous iron (100 mm) in ammonium for-
mate buffer (50 mm, pH 7.5) were subjected to 1H NMR analysis
at 1.5 min intervals over a 30-min reaction. With both WT and
K241A KDM4A, the triplet 1H resonance at dH=2.4 ppm (corre-
sponding to 2OG) decreased in intensity during the analysis,
while a new singlet 1H resonance at dH=2.3 ppm, correspond-
ing to succinate emerged (Figures 1C and S3). The initial succi-
nate formation rates were near identical with both enzymes
(WT=1.35 mmmin@1, K241A=1.55 mmmin@1, Figure 1C, note:
2OG turnover was too slow for accurate determination of the
Michaelis–Menten kinetic parameters). Uncoupled 2OG turn-
over by the WT and K241A enzymes was inhibited by the 2OG
competitor N-oxalylglycine; interestingly, inhibition was more
Scheme 1. Outline mechanism of KDM4A-catalysed demethylation. After binding of 2OG to the ferrous iron at the active site, the histone substrate binds. O2
then coordinates to the iron, thereby initiating an oxidative decarboxylation reaction, forming succinate, CO2 and a reactive iron(IV)-oxo intermediate. Inser-
tion of the iron(IV)-bound oxygen atom into a histone methyl C@H bond occurs, with resultant reduction of the iron(IV) to iron(II). The hemiaminal product
on the histone then fragments, giving the demethylated product and formaldehyde. Inset. A view of an X-ray crystal structure of KDM4A complexed with Ni
(substituting for FeII, green)), N-oxalylglycine (NOG; a 2OG analogue, blue) and a histone H3 fragment peptide Ne-trimethylated at Lys9 (red). Lys241 is shown
in pale green (PDB ID: 2OQ6).
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pronounced with the KDM4-selective inhibitor JIB-04 (Fig-
ures S4 and S5),[14] which is proposed to interact with K241 in
the KDM4A active site (inferred from modelling studies).[15] Re-
sults from NMR binding experiments support preferential bind-
ing of JIB-04 to the K241A variant over the WT enzyme (provi-
sional KD(JIB-04)=22:5 and 7:2 mm for WT and K241A, respec-
tively, Figures 1D and S6), thus implying no/suboptimal inter-
actions between JIB-04 and K241. Experiments were then con-
ducted in the presence of a histone H3 eight-residue fragment
peptide containing Ne-trimethyllysine at position 9 (H3K9me3,
sequence: ARKme3STGGK). Initial succinate formation rates
were markedly increased for both the WT and K241A enzymes;
this implied binding of the histone fragment, which is reported
to stimulate succinate formation by KDM4,[16] and potentially
demethylation. The 1H resonances corresponding to lysyl
methyl groups were obscured by residual glycerol and HEPES
from the enzyme stocks; this hindered the detection of KDM
activity. Stimulation of succinate formation was greater for WT
than for K241A KDM4A.
MS studies were then carried out to investigate whether de-
methylation by K241A KDM4A is stimulated by increasing the
O2 concentration. KDM assays (using the same final concentra-
tions of components as above) were carried out with the use
of a Mass Flow Controller (Brooks Instruments) to equilibrate
the reactions at either 20 or 80% O2, as described;
[12b] reactions
were left for 10 min before quenching (with methanol) and
MALDI-TOF MS analysis. As reported, the KDM activity of WT
KDM4A increased with increasing O2 concentration (from 31 to
46% demethylation, Figure 1E).[12b] However, only trace de-
methylation (<5%) was observed in the samples with K241A
KDM4A at either 20 or 80% oxygen (Figure 1E); this indicated
that oxygen binding/recruitment does not limiting the KDM
activity of the K241A variant.
The crystal structures of KDM4A appear to show that K241
interacts with the H3 fragment peptide substrate (Scheme 1,
Figure 1. Evidence that Lys241 in KDM4A is involved in catalysis but not O2 binding. A) MALDI-TOF MS spectra showing KDM4A-catalysed demethylation of
H3K9me3 peptide (ARTKQTARKme3STGGKA; 40 min; 37 8C). Clear demethylation is observed with WT KDM4A (red); however, only trace levels of dimethylated
product are apparent in the sample with K241A KDM4A (blue). B) The percentage demethylation of trimethylated H3K9 peptide (sequence: ARTKQTARK-
me3STGGKA), H3K36 peptide (SAPATGGVKme3KPHRYR) and H1.4K26 peptide (TPVKKKARKme3SAGAAK) catalysed by WT and K241A KDM4A. Only low-level
demethylation was observed with the K241A variant. C) Succinate formation in samples of KDM4A (WT or K241A, 20.5 mm), 2OG (2 mm), ascorbate (1 mm),
and ferrous iron (100 mm) in 50 mm ammonium formate buffer pH 7.5 over time, in the presence or absence of ARKme3STGGK; no-enzyme control : green.
Succinate formation rates in the absence of peptide are near identical for WT and K241A KDM4A. Succinate formation is stimulated by H3K9me3 peptide, but
more readily with WT KDM4A. D) Binding curves showing binding of the KDM4-selective inhibitor JIB-04 to WT and K241A KDM4A. JIB-04 is proposed to inter-
act with K241 in the KDM4 active site; however, binding to K241A appears stronger. E) Percentage demethylation of H3K9me3 peptide catalysed by WT and
K241A KDM4A at 20 and 80% (v/v) O2 after 10 min at 37 8C. Demethylation increases with increased O2 concentration with WT KDM4A; however, the extent
of demethylation with K241A KDM4A was very low (<5%). F) The binding of a fluorescence-labelled histone fragment (ARTKQTARKme3STGGKA-fluorescein)
is similar for WT and K241A KDM4A, respectively.
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inset) ;[17] we therefore investigated whether the KDM activity
of the K241A variant is limited by weakened substrate binding.
The binding of WT and K241A KDM4A to a histone fragment
peptide was evaluated in a fluorescence polarisation assay. A
15-residue H3K9me3 peptide C-terminally labelled with a fluo-
rescein fluorophore, that is, ARTKQTARKme3STGGKA-fluores-
cein, was found by MALDI-TOF MS to be a WT KDM4A de-
methylation substrate (a mass shift of @14 Da was observed
under standard conditions). The labelled substrate (20 nm) was
incubated with the 2OG analogue N-oxalylglycine (1 mm),[18]
NiCl2 (10 mm) and various concentrations of the WT and K241A
enzymes (0–20 mm). The fluorescence emission spectra of the
samples parallel and perpendicular to the excitation plane
were then measured, and used to calculate the fluorescence
polarisation at each enzyme concentration. The apparent bind-
ing constants for peptide binding were near identical for both
enzymes (3.06:2.9 mm for WT KDM4A, and 4.54:2.1 mm for
K241A KDM4A, respectively), thus indicating that mutation of
the K241 residue to alanine does not alter the affinity of
KDM4A for the peptide substrate (Figure 1F).
The overall MS, NMR spectroscopy and fluorescence polari-
sation studies imply that K241 has a role in KDM4A catalysis.
However, the observation that the K241A variant catalyses un-
coupled succinate formation with comparable efficiency to the
WT implies that the role(s) of K241 during catalysis do not
involve (at least initial) binding of O2.
[13] Thus, the observed
mixed-mode inhibition[14] of K241A by JIB-04 probably does
not reflect direct disruption of O2 binding. Succinate formation
by the K241A variant is stimulated by a histone fragment pep-
tide, and a fluorescently labelled histone peptide binds in a
similarly tight manner to the WT and K241A KDM4A. Thus,
K241 appears to have a role in coupling 2OG turnover to sub-
strate oxidation. One possibility is that K241 helps to orientate
the methylated lysyl side chain within the KDM4A active site,
thereby ensuring efficient oxidation of a methyl C@H bond
after succinate formation. K241 might also limit the access to
the active site of water molecules that could quench the reac-
tive iron(IV)-oxo intermediate before methyl C@H bond oxida-
tion can occur. Targeting K241 is of interest both with respect
to developing classical tightly binding inhibitors and to devel-
oping inhibitors that decouple 2OG and substrate oxidation.
Such inhibitors are of interest because uncoupling could cause
inactivation; in the absence of “prime” substrate, self-oxidation
of 2OG oxygenases can occur, either directly or through the
production of reactive oxygen species.[19] Therefore, molecules
that bind and induce self-oxidation before dissociating, for
example, K241 binders, have the potential to be catalytic in-
activators.
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